Wednesday, February 8, 2012

Novadaq partnering strategy hits marketing milestone

January 17, 2012 by leonardzehr · Leave a Comment

Novadaq Technologies (TSX:NDQ), a maker of real-time fluorescence imaging products for the operating room, reached a significant milestone earlier this month when it named MAQUET Cardiovascular as the exclusive distributor of its CO2 Heart Laser system in the U.S. “We have now completed our strategic agenda of partnering each one of our first four surgical [...]

Filed under Tuesday Features · Tagged with angina, breast reconstructive, CO2 Heart Laser, da Vinci surgical robotic system, Dr. Arun Menawat, Duke University Hospital, fluorescence imaging, gastrointestinal, GI, gynecology, head and neck surgery, Intuitive Surgical, J.T. Haresco, JMP Securities analyst, Johns Hopkins Hospital, Kinetic Concepts, LifeCell, Maquet Cardiovascular, Mayo Methodist Hospital, MD Anderson Cancer Center, Montefiore Medical Center, Novadaq Technologies, revascularization, SPY Elite System, SPY imaging, Stanford Hospital, TMR, Transmyocardial Revascularization, TSX:NDQ, UCLA Head & Neck, University of North Carolina, urology, vascular surgery, wound car

Riding the Next Wave

June 8, 2010 by leonardzehr · 1 Comment

No, we’re not talking about the north coast of Maui but rather a new research platform from long-time biotech analyst David Martin of Dundee Securities. “If I’m going to recommend that investors own a basket of biotech stocks, it makes sense that I ought to initiate on a basket of stocks rather than make one-off [...]

Filed under Tuesday Features · Tagged with Anormed, Arius, ASSERT trial, Biochem Pharma, Bioniche, BNC, Da Vinci robotic surgery system, David Martin, Dundee Securities, ENDP, iCo, ID Biomedical, Intuitive Surgical, NDQ, Next Wave, Novadaq, Resverlogix, RVX, RVX-208, SDI, sepsis, Spectral Diagnostics, SPY imaging, Toraymyxin, Urocidin